MarketPeel
Insider Trading Intelligence
RL

Rodney W. Lappe

DSGN
DIRECTOR · DESIGN THERAPEUTICS, INC. · CIK 0001579826
FILING MIX · LIFETIME100%/0%
BUYS
11
SELLS
0
TOTAL VALUE
$268.7K
COMPANIES
1
ACTIVE SINCE
Mar 2021
HOLDINGS NOW
30,000
AVG SELL PX
TRADE KIND
SHOWING 11 / 11
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Rodney W. Lappe, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+66.67%+3.26%+0.42%+2.84%-2.00%
14d3+33.33%-3.27%+1.11%-4.39%-10.26%
30d3+33.33%-4.84%+0.90%-5.75%-10.78%
60d3+33.33%-5.87%+6.30%-12.16%-14.05%
90d3+33.33%-6.72%+6.88%-13.60%-14.65%
180d3+33.33%-2.06%+15.17%-17.23%-34.06%
1y3+33.33%+3.67%+24.03%-20.36%-63.50%
2y3+33.33%+30.80%+40.67%-9.88%-75.46%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
DSGN · 30,000 shares · as of Jun 9, 2026
033,25666,51299,768133,02420222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 11 buys / 0 sellsCOVERAGE · 22 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
DSGN
DESIGN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
30,00030,000Jun 9, 2026Jun 11, 2026View →
DSGN
DESIGN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
19,00019,000Jun 10, 2025Jun 12, 2025View →
DSGN
DESIGN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
25,99325,993Jan 2, 2025Jan 6, 2025View →
DSGN
DESIGN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
19,00019,000Jun 13, 2024Jun 17, 2024View →
DSGN
DESIGN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
69,18669,186Dec 1, 2023Dec 5, 2023View →
DSGN
DESIGN THERAPEUTICS, INC.
PURCHASE
21,000$2.35$49.3K133,024Sep 29, 2023Oct 2, 2023View →
DSGN
DESIGN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
15,00015,000May 31, 2023Jun 2, 2023View →
DSGN
DESIGN THERAPEUTICS, INC.
PURCHASE
15,000$7.96$119.4K112,024Dec 9, 2022Dec 12, 2022View →
DSGN
DESIGN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
15,00015,000Jun 15, 2022Jun 16, 2022View →
DSGN
DESIGN THERAPEUTICS, INC.
PURCHASE
5,000$20.00$100.0K97,024Mar 30, 2021Mar 31, 2021View →
DSGN
DESIGN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
15,00015,000Mar 25, 2021Mar 26, 2021View →
Other insiders · DSGN
Loading peer insiders…
About this filer
CIK 0001579826
ROLE
Director
PRIMARY
DSGN
COMPANIES
1
ACTIVE SINCE
Mar 2021
MARKETPEEL · /INSIDER/0001579826DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback